Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · IEX Real-Time Price · USD
2.970
-0.220 (-6.90%)
Apr 25, 2024, 12:02 PM EDT - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $48.17 million as of April 25, 2024. Its market cap has decreased by -16.94% in one year.
Market Cap
48.17M
Enterprise Value
33.22M
1-Year Change
-16.94%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $48.17M, a decrease of -61.35%. That is a compound annual growth rate of -26.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 51.70M | -6.00% |
Apr 23, 2024 | 55.00M | 7.00% |
Apr 22, 2024 | 51.40M | -0.39% |
Apr 19, 2024 | 51.60M | 0.98% |
Apr 18, 2024 | 51.10M | -0.97% |
Apr 17, 2024 | 51.60M | 0.58% |
Apr 16, 2024 | 51.30M | 2.40% |
Apr 15, 2024 | 50.10M | -1.96% |
Apr 12, 2024 | 51.10M | -6.24% |
Apr 11, 2024 | 54.50M | 0.55% |
Apr 10, 2024 | 54.20M | -1.09% |
Apr 9, 2024 | 54.80M | -1.44% |
Apr 8, 2024 | 55.60M | -3.64% |
Apr 5, 2024 | 57.70M | -0.69% |
Apr 4, 2024 | 58.10M | -10.20% |
Apr 3, 2024 | 64.70M | 2.54% |
Apr 2, 2024 | 63.10M | 1.61% |
Apr 1, 2024 | 62.10M | 1.64% |
Mar 28, 2024 | 61.10M | 0.99% |
Mar 27, 2024 | 60.50M | -1.79% |
Mar 26, 2024 | 61.60M | 30.79% |
Mar 25, 2024 | 47.10M | -10.11% |
Mar 22, 2024 | 52.40M | -7.09% |
Mar 21, 2024 | 56.40M | 2.55% |
Mar 20, 2024 | 55.00M | 0.18% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
XORTX Therapeutics | 53.97M |
AVROBIO | 53.83M |
Intensity Therapeutics | 53.47M |
HeartBeam | 52.66M |
Ocean Biomedical | 52.15M |
NeueHealth | 51.27M |
American Oncology Network | 51.13M |
Checkpoint Therapeutics | 50.73M |